![]() First Quarter 2013 Earnings Release April 23, 2013 Exhibit 99.1 |
![]() Agenda • IDEX Outlook • Q1 Financial Performance • Q1 Segment Performance • Fluid & Metering • Health & Science • Fire & Safety / Diversified • Guidance Update • Q&A IDEX PROPRIETARY & CONFIDENTIAL 2 |
![]() Replay Information • Dial toll–free: 855.859.2056 • International: 404.537.3406 • Conference ID: #26072848 • Log on to: www.idexcorp.com 3 IDEX PROPRIETARY & CONFIDENTIAL |
![]() Cautionary Statement Under the Private Securities Litigation Reform Act This presentation and discussion will include forward- looking statements. Our actual performance may differ materially from that indicated or suggested by any such statements. There are a number of factors that could cause those differences, including those presented in our most recent annual report and other company filings with the SEC. 4 IDEX PROPRIETARY & CONFIDENTIAL |
![]() IDEX Q1 Financial Performance Revenue Organic: 1% decline 90 bps expansion 28% growth 12% growth EPS* Operating Margin* Free Cash Flow* * Q1 2012 EPS / Operating Margin data adjusted for restructuring expenses ($4.9M) Outstanding EPS, Operating Margins & FCF performance Q1 2013 FCF of $0.81 cents per share 5 IDEX PROPRIETARY & CONFIDENTIAL |
![]() 6 Fluid & Metering Orders Revenue Q1 Sales Mix: Organic -1% Acquisition 0% Fx 0% Total -1% Q1 Summary: Excellent improvement in operating margins driven by productivity initiatives Backlog grew by $9 million in the quarter Orders were impacted in Q1 by the sustained cold weather across North America North American and Indian Energy markets remain robust Municipal water services showing signs of stabilization Organic: 1% decline 50 bps expansion Organic: 3% decline Operating Margin* * Q1 2012 Operating Margin data adjusted for restructuring expense Q1 Operating margins of 22.7% up 50 bps IDEX PROPRIETARY & CONFIDENTIAL |
![]() Health & Science Orders Revenue Organic: 7% decline 40 bps expansion Organic: 2% decline Operating Margin* * Q1 2012 Operating Margin data adjusted for restructuring expense Q1 Sales Mix: Organic -7% Acquisition 7% Fx -1% Total -1% Q1 Summary: Sequential orders showed broad-based growth Backlog grew by $6 million in the quarter Operating margins expanded 40 basis points on the strength of focused cost-out initiatives Scientific Fluidics demonstrated strong growth in Asia Stabilized cost structure improves Optics & Photonics long-term prospects Successfully managed costs to deliver margin expansion 7 IDEX PROPRIETARY & CONFIDENTIAL |
![]() Fire & Safety/Diversified Orders Revenue Organic: 7% growth 200 bps expansion Organic: 13% decline Operating Margin* * Q1 2012 Operating Margin data adjusted for restructuring expense Q1 Sales Mix: Organic 7% Acquisition 0% Fx 0% Total 7% Q1 Summary: Op margins up 200 bps YOY and 110 sequentially Backlog grew by $5 million in the quarter Large dispensing replenishment order in Q1 2012 creates difficult comparison Dispensing has had excellent traction with new X-Smart product Rescue seeing strength in emerging markets, but Europe remains weak Fire seeing benefits of facility consolidation, while US market remains strong Q1 Operating Margin of 25.3% up 200 bps 8 IDEX PROPRIETARY & CONFIDENTIAL |
![]() 9 Outlook: 2013 Guidance Summary Q2 2013 • EPS estimate range: $0.73 – $0.75 • Organic revenue growth ~ 2 – 3% • Positive revenue impact from acquisition of ~ 3% • Operating margin ~ 19% FY 2013 • EPS estimate range: $2.85 – $2.95 – Low-to-mid single digit organic revenue growth – Positive revenue impact from acquisition of ~ 1% – Operating margin ~ 19% – Negative Fx impact ~ 1% to sales • Other modeling items – Tax rate ~ 29 – 29.5% – Cap Ex ~ $40M – Free Cash Flow will significantly exceed net income – Continued share repurchases – EPS estimate excludes future acquisitions and associated costs and charges IDEX PROPRIETARY & CONFIDENTIAL |
![]() Q&A 10 IDEX PROPRIETARY & CONFIDENTIAL |